Background illustration for clinical trials search

Paid Clinical Trials Nashville

Discover 1,239 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

for
Lymphoma, Large B-Cell, Diffuse
Location: Nashville TN, Elizabethtown KY, Knoxville TN,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06890884

Phase 2, Recruiting

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

for
Pancreatic Ductal Adenocarcinoma, Non Small Cell Lung Cancer,
Location: Nashville TN, St Louis MO, Ann Arbor MI,
Sponsor: Verastem, Inc.

Sex: All

Age: 18+

Code: NCT07020221

Phase 1, Phase 2, Recruiting

Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

for
Malignant Mesothelioma, Metastatic Malignant Solid Tumor,
Location: Nashville TN, Denver CO, Chicago IL, Cleveland OH,
Sponsor: InSilico Medicine Hong Kong Limited

Sex: All

Age: 18+

Code: NCT06566079

Phase 1, Phase 2, Recruiting

A Phase 1 Study of the Safety and Tolerability of CTX-10726

for
Gastroesophageal Cancer (GC), Hepatocellular Carcinoma (HCC),
Location: Nashville TN, Greenville SC, Pittsburgh PA,
Sponsor: Compass Therapeutics

Sex: All

Age: 18+

Code: NCT07419841

Phase 1, Recruiting

A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

for
Small Cell Lung Cancer Extensive Stage
Location: Nashville TN, Knoxville TN, Memphis TN, Edgewood KY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07227597

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

for
CRC (Colorectal Cancer)
Location: Aurora CO, Knoxville TN, Carterville IL, Asheville NC,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07284849

Phase 3, Recruiting

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

for
Metastatic Castration Resistant Prostate Cancer (mCRPC),
Location: Nashville TN, Myrtle Beach SC, Oklahoma City OK,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT03460977

Phase 1, Recruiting

DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic Solid Tumors
Location: Nashville TN, Birmingham AL, Columbus OH,
Sponsor: DynamiCure Biotechnology

Sex: All

Age: 18+

Code: NCT05785754

Phase 1, Recruiting

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Nashville TN, Cincinnati OH, Indianapolis IN,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06095505

Phase 2, Recruiting

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

for
Advanced Solid Tumor, Advanced Breast Cancer,
Location: Nashville TN, Denver CO, Columbus OH, Durham NC,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06120283

Phase 1, Recruiting

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

for
Oncology, MEK Mutation, RAF Gene Mutation,
Location: Nashville TN, Denver CO, Pittsburgh PA, Fairfax VA,
Sponsor: Nested Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT06326411

Phase 1, Recruiting

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

for
MTAP-deleted Solid Tumors
Location: Nashville TN, Grand Rapids MI, Milwaukee WI, Irving TX,
Sponsor: Bayer

Sex: All

Age: 18+

Code: NCT06914128

Phase 1, Phase 2, Recruiting

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Nashville TN, Denver CO, Columbus OH, Detroit MI,
Sponsor: Nuvalent Inc.

Sex: All

Age: 18+

Code: NCT06521554

Phase 1, Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors, Colorectal Cancer
Location: Nashville TN, Louisville KY, Atlanta GA, Ann Arbor MI,
Sponsor: Vividion Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06004245

Phase 1, Recruiting

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

for
Breast Cancer, Gastric Cancer, Esophageal Cancer,
Location: Nashville TN, Dallas TX, Houston TX, New York NY,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06695845

Phase 2, Recruiting

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

for
Diffuse Large B-Cell Lymphoma
Location: Nashville TN, Owensboro KY, Louisville KY, Knoxville TN,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06717347

Phase 3, Recruiting

QTX3034 in Patients With KRAS G12D Mutation

for
Solid Tumors
Location: Nashville TN, Durham NC, Fairfax VA, Oklahoma City OK,
Sponsor: Quanta Therapeutics

Sex: All

Age: 18+

Code: NCT06227377

Phase 1, Recruiting

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

for
Advanced Breast Cancer
Location: Nashville TN, Germantown TN, Atlanta GA, Chicago IL,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06638307

Phase 1, Recruiting

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

for
Non-Small Cell Lung Cancer (NSCLC)
Location: Nashville TN, Memphis TN, Asheville NC, Dayton OH,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT05920356

Phase 3, Recruiting

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Melanoma, Head and Neck Cancer,
Location: Nashville TN, St Louis MO, Chicago IL, Rockville MD,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06172478

Phase 2, Recruiting